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Abstract
Background: Tick borne encephalitis is the most frequent vector-transmitted infectious disease of the central
nervous system in Europe and Asia. The disease caused by European subtype of tick borne encephalitis virus has
typically a biphasic clinical course with the second phase presenting as meningitis, meningoencephalitis, or
meningoencephalomyelitis. Cerebrospinal fluid pleocytosis is considered a condition sine qua non for the diagnosis of
neurologic involvement in tick borne encephalitis, which in routine clinical practice is confirmed by demonstration of
serum IgM and IgG antibodies to tick borne encephalitis virus.
Case presentation: Here we present a patient from Slovenia, an area highly endemic for tick borne encephalitis, with
encephalitis but without cerebrospinal fluid pleocytosis in whom tick borne encephalitis virus infection of the central
nervous system was demonstrated.
Conclusion: Cerebrospinal fluid pleocytosis is not mandatory in encephalitis caused by tick borne encephalitis virus. In
daily clinical practice, in patients with neurologic symptoms/signs compatible with tick borne encephalitis and the risk
of exposure to ticks in a tick borne encephalitis endemic region, the search for central nervous system infection with
tick borne encephalitis virus is warranted despite the lack of cerebrospinal fluid pleocytosis.
Background
Tick borne encephalitis (TBE) is the most frequent vector-
transmitted infectious disease of the central nervous system
(CNS) in Europe and Asia and is considered an emerging
disease due to its rising incidence and the spread of en-
demic areas in recent decades [1]. TBE caused by European
subtype of TBE virus (TBEV) has typically a biphasic clin-
ical course with the second phase presenting as meningi-
tis, meningoencephalitis, or meningoencephalomyelitis
[2]. Cerebrospinal fluid (CSF) pleocytosis is considered a
condition sine qua non for the diagnosis of CNS involve-
ment in TBE, which in routine clinical practice is con-
firmed by demonstration of serum IgM and IgG antibodies
to TBEV [2-4]. Cases of TBE with neurologic involvement
but without CSF pleocytosis have been published [5-7],
however, only the case recently reported by Pöschl et al.
was convincingly substantiated [5]. Here we present a
patient from Slovenia, an area highly endemic for TBE [8],
with clinical features of encephalitis, who fulfilled criteria
for recent CNS infection with TBEV although he had no
CSF pleocytosis.
Case presentation
A 79-year-old man with arterial hypertension and chronic
venous ulcers on both shins, fell ill acutely with diarrhea,
fatigue and sleepiness in midsummer 2013. After a week,
diarrhea stopped, but he became febrile up to 38.5°C and
was no longer able to walk independently due to general
weakness. As a beekeeper he had been exposed to ticks in
the past but could not remember having had a tick bite
during the preceding few months. At admission to hos-
pital on day 8 of his illness, he was lethargic, disoriented,
but without signs of meningeal irritation. His blood pres-
sure was 133/83 mmHg, heart rate 99/min, breathing rate
30/min and axillary temperature 38.9°C. Routine laboratory
blood tests revealed normal blood cell count, mild hypo-
natremia (Na 129; normal 135–145 mmol/l), and slightly
elevated concentrations of C-reactive protein (32 mg/l;
normal 0–5 mg/l), liver enzymes (aspartate aminotrans-
ferase 0.73; normal ≤0.58 μkat/l, gamma-glutamyl trans-
peptidase 1.12 μkat/l; normal ≤0.92 μkat/l) and creatinine
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(101 μmol/l; normal 44–97 μmol/l). CSF examination
yielded elevated protein concentration (1.31 g/l; normal
0.15–0.45 g/l), but normal leukocyte count (3 × 106/l;
normal ≤5 × 106/l) and glucose concentration. In the
following days the patient remained febrile up to 39.4°C.
On day 10, tremor of hands and tongue appeared and
his mental status deteriorated to somnolence. Computed
tomography of the brain showed only mild periventricular
leukopathy. Repeated CSF analyses on day 14 and 23 re-
vealed elevated protein concentrations (1.23, and 2.02 g/l,
respectively), but still no pleocytosis (CSF leukocyte count
1, and 2 × 106/l, respectively). PCR analyses of CSF for the
presence of TBEV on day 8 and 23 were negative as were
for HSV 1, HSV 2, VZV, and enteroviruses. Based on sero-
logical results the patient did not have Lyme neuroborre-
liosis. However, serum IgM and IgG antibodies to TBEV
were demonstrated using enzyme linked immunosorbent
assay - ELISA (Enzygnost Anti-TBE/FSME Virus IgG,
IgM; Siemens, Marburg, Germany) (Table 1). The follow-
up levels of specific serum antibodies and the avidity of
specific serum IgG (12.7%, 15.4%, and 51.6% on day 14,
21, and 65, respectively) indicated recent infection with
TBEV. In addition, demonstration of intrathecal produc-
tion of anti-TBEV IgM and IgG verified CNS infection
with TBEV (Table 1). From day 14 the patient was no lon-
ger febrile and his mental and physical status progressively
improved. Hospitalization was prolonged because of hos-
pital acquired pneumonia which was treated with amoxi-
cillin/clavulanate. At transfer to a nursing facility on day
32 the patient was afebrile, completely oriented, feeble,
but without focal neurological deficit. Routine laboratory
test results were unremarkable.
Conclusions
Presenting symptoms and signs of TBE are nonspecific
and similar as in acute aseptic meningoencephalitis of
other etiologies with fever in 92%, vomiting in 38%, head-
ache in 67-100%, altered consciousness in 12–35.5%, sei-
zures in 0.3-3.3%, tremor in 7-78%, dysphasia in 0.7-3.8%,
spinal nerve paralysis in 2.7-15%, and cranial nerve paraly-
sis in 3.3-11% of cases [2,10]. Accordingly, our patient with
fever, altered consciousness and tremor of the hands and
tongue had clinical indications of acute encephalitis.
In our patient, recent infection with TBEV was demon-
strated by the presence of specific IgM and IgG antibodies
in serum and further substantiated with the appropriate
increase in antibody levels and IgG avidity in convalescent
samples. Since detailed history revealed that he had not
had TBE in the past, had not traveled outside Slovenia,
nor was he vaccinated against TBE, yellow fever or Japa-
nese encephalitis, and he had negative serum antibodies
against West Nile virus, the only potential coinfecting
flavivirus in Slovenia, the possibility of false positive
serological results for TBE due to cross-reaction is highly
improbable. In routine clinical practice the finding of spe-
cific IgM and IgG serum antibodies in a patient residing
in endemic area, who has clinical signs/symptoms of men-
ingitis/encephalitis associated with elevated CSF leukocyte
count, is considered confirmatory for TBE [2,3]. However,
demonstration of recent infection with TBEV by itself
does not attest for CNS involvement; in fact the majority
of infections with TBEV are asymptomatic or without
prominent morbidity [2]. For a reliable diagnosis of un-
usual TBE cases such as ours without CSF pleocytosis,
which is most likely rather rare and therefore associated
with low pre-test probability, not only evidence of a recent
infection, but also evidence of CNS infection with TBEV is
needed. We were unable to demonstrate the presence of
TBEV in CSF by PCR, which is not surprising in regard to
earlier reports that the virus can be detected by PCR in
blood during the initial phase of TBE, but extremely rarely
in blood or CSF during the second phase of the disease
[11]. However, we ascertained CNS infection by demon-
stration of intrathecal synthesis of specific antibodies to
TBEV, which is a much more sensitive approach for veri-
fying CNS infection. The main source of CSF antibodies
are lymphocytes B, but in patients with TBE lymphocytes
B comprise only 3-5% of CSF lymphocyte population [12].
Therefore, one may hypothesize, that the major source of
CSF antibodies are lymphocytes B accumulated in the
perivascular spaces of brain parenchyma [13].
In reports including large number of patients with
proven TBE, CSF pleocytosis was established in all cases
[2,4,10,14]. This finding, however, might be due to a se-
lection bias because in these studies CSF pleocytosis was
one of the inclusion criteria for the diagnosis of TBE
[15]. Our case, together with the recently published case
by Pöschl et al. [5], and some earlier less convincing re-
ports [6,7], show that CSF pleocytosis is not mandatory
in patients with encephalitis caused by TBEV. This is in







IgM in serum IgG in serum IgM in CSF IgG in CSF
Day 14 1.473 78.4 0.601 53.7 NA NA
Day 23 1.133 130 0.676 89.7 48.6 40.2
TBEV, tick-borne encephalitis virus; CSF, cerebrospinal fluid; NA, not available.
aAntibody index of intrathecal synthesis of anti-TBEV IgM and IgG calculated according to Reiber’s formula [9].
Stupica et al. BMC Infectious Diseases 2014, 14:614 Page 2 of 3
http://www.biomedcentral.com/1471-2334/14/614
accordance with the reports on encephalitis caused by
some other viruses such as herpes simplex 1 in which
about 3% of cases take place with normal CSF leukocyte
count [16]. The frequency of encephalitis without CSF
pleocytosis caused by TBEV infection remains to be de-
termined. However, the paucity of reports implies that
such presentation is most probably very rare.
The findings in our patient suggest that in daily clinical
practice, in patients with symptoms/signs of encephalitis
compatible with TBE and the risk of exposure to ticks in a
TBE endemic region, the search for infection with TBEV
is warranted despite the lack of CSF pleocytosis. However,
to reliably prove that the encephalitis with normal CSF
white cell count is caused by TBEV, a proof of TBEV CNS
infection is needed besides the usual diagnostic require-
ments i.e., the evidence of a recent infection with TBEV
denoted by the presence of specific serum IgM and IgG
antibodies.
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